EnerSpar Corp. (TSE:NRX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
NurExone Biologic Inc. has announced promising data for ExoPTEN, its nanodrug that demonstrates precise targeting of inflammation and injury sites, which is a crucial step towards commercial manufacturing. The study validated the use of NurExone’s exosomes for drug delivery and the quality of siRNA from its new GMP-compliant manufacturing partner. These advancements bring the company closer to clinical trials and potential commercialization of their non-invasive therapies for Central Nervous System injuries.
For further insights into TSE:NRX stock, check out TipRanks’ Stock Analysis page.
